Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Comprehensive Control of Human Papillomavirus Infections and Related Diseases</title><author><name sortKey="Bosch, F Xavier" sort="Bosch, F Xavier" uniqKey="Bosch F" first="F. Xavier" last="Bosch">F. Xavier Bosch</name><affiliation><nlm:aff id="A1">Cancer Epidemiology Research Program (CERP), Institut Català d’Oncologia – Catalan Institute of Oncology (ICO), IDIBELL, L’Hospitalet de Llobregat (Barcelona), Spain</nlm:aff></affiliation></author><author><name sortKey="Broker, Thomas R" sort="Broker, Thomas R" uniqKey="Broker T" first="Thomas R." last="Broker">Thomas R. Broker</name><affiliation><nlm:aff id="A2">University of Alabama at Birmingham, Biochemistry and Molecular Genetics, Birmingham, Alabama, USA</nlm:aff></affiliation></author><author><name sortKey="Forman, David" sort="Forman, David" uniqKey="Forman D" first="David" last="Forman">David Forman</name><affiliation><nlm:aff id="A3">Section of Cancer Information, International Agency for Research on Cancer, Lyon, France</nlm:aff></affiliation></author><author><name sortKey="Moscicki, Anna Barbara" sort="Moscicki, Anna Barbara" uniqKey="Moscicki A" first="Anna-Barbara" last="Moscicki">Anna-Barbara Moscicki</name><affiliation><nlm:aff id="A4">Division of Adolescent Medicine, Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA</nlm:aff></affiliation></author><author><name sortKey="Gillison, Maura L" sort="Gillison, Maura L" uniqKey="Gillison M" first="Maura L." last="Gillison">Maura L. Gillison</name><affiliation><nlm:aff id="A5">Viral Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA</nlm:aff></affiliation></author><author><name sortKey="Doorbar, John" sort="Doorbar, John" uniqKey="Doorbar J" first="John" last="Doorbar">John Doorbar</name><affiliation><nlm:aff id="A6">Division of Virology, National Institute for Medical Research, London, UK</nlm:aff></affiliation></author><author><name sortKey="Stern, Peter L" sort="Stern, Peter L" uniqKey="Stern P" first="Peter L." last="Stern">Peter L. Stern</name><affiliation><nlm:aff id="A7">Paterson Institute for Cancer Research, University of Manchester, Manchester, UK</nlm:aff></affiliation></author><author><name sortKey="Stanley, Margaret" sort="Stanley, Margaret" uniqKey="Stanley M" first="Margaret" last="Stanley">Margaret Stanley</name><affiliation><nlm:aff id="A8">Department of Pathology, Tennis Court Road, Cambridge, UK</nlm:aff></affiliation></author><author><name sortKey="Arbyn, Marc" sort="Arbyn, Marc" uniqKey="Arbyn M" first="Marc" last="Arbyn">Marc Arbyn</name><affiliation><nlm:aff id="A9">Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium</nlm:aff></affiliation><affiliation><nlm:aff id="A10">Laboratory for Cell Biology and Histology, University of Antwerp, Antwerp, Belgium</nlm:aff></affiliation></author><author><name sortKey="Poljak, Mario" sort="Poljak, Mario" uniqKey="Poljak M" first="Mario" last="Poljak">Mario Poljak</name><affiliation><nlm:aff id="A11">Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia</nlm:aff></affiliation></author><author><name sortKey="Cuzick, Jack" sort="Cuzick, Jack" uniqKey="Cuzick J" first="Jack" last="Cuzick">Jack Cuzick</name><affiliation><nlm:aff id="A12">Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK</nlm:aff></affiliation></author><author><name sortKey="Castle, Philip E" sort="Castle, Philip E" uniqKey="Castle P" first="Philip E." last="Castle">Philip E. Castle</name><affiliation><nlm:aff id="A13">Global Cancer Initiative, Chestertown, MD, USA</nlm:aff></affiliation></author><author><name sortKey="Schiller, John T" sort="Schiller, John T" uniqKey="Schiller J" first="John T." last="Schiller">John T. Schiller</name><affiliation><nlm:aff id="A14">Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA</nlm:aff></affiliation></author><author><name sortKey="Markowitz, Lauri E" sort="Markowitz, Lauri E" uniqKey="Markowitz L" first="Lauri E." last="Markowitz">Lauri E. Markowitz</name><affiliation><nlm:aff id="A15">National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA</nlm:aff></affiliation></author><author><name sortKey="Fisher, William A" sort="Fisher, William A" uniqKey="Fisher W" first="William A." last="Fisher">William A. Fisher</name><affiliation><nlm:aff id="A16">Department of Psychology and Department of Obstetrics and Gynaecology, University of Western Ontario, Social Sciences Centre 7428, London, Ontario, Canada</nlm:aff></affiliation></author><author><name sortKey="Canfell, Karen" sort="Canfell, Karen" uniqKey="Canfell K" first="Karen" last="Canfell">Karen Canfell</name><affiliation><nlm:aff id="A17">Lowy Cancer Research Centre, Prince of Wales Clinical School, The University of NSW, Australia and Cancer Epidemiology Research Unit, Cancer Council NSW, Sydney, Australia (past affiliation)</nlm:aff></affiliation></author><author><name sortKey="Denny, Lynette A" sort="Denny, Lynette A" uniqKey="Denny L" first="Lynette A." last="Denny">Lynette A. Denny</name><affiliation><nlm:aff id="A18">Department Obstetrics and Gynaecology and Institute of Infectious Diseases and Molecular Medicine, University of Cape Town/Groote Schuur Hospital, Cape Town, South Africa</nlm:aff></affiliation></author><author><name sortKey="Franco, Eduardo L" sort="Franco, Eduardo L" uniqKey="Franco E" first="Eduardo L." last="Franco">Eduardo L. Franco</name><affiliation><nlm:aff id="A19">Division of Cancer Epidemiology, McGill University, Montreal, Canada</nlm:aff></affiliation></author><author><name sortKey="Steben, Marc" sort="Steben, Marc" uniqKey="Steben M" first="Marc" last="Steben">Marc Steben</name><affiliation><nlm:aff id="A20">Institut National de Santé Publique du Québec, Montréal, Québec, Canada</nlm:aff></affiliation></author><author><name sortKey="Kane, Mark A" sort="Kane, Mark A" uniqKey="Kane M" first="Mark A." last="Kane">Mark A. Kane</name><affiliation><nlm:aff id="A21">Consultant on Immunization Policy, Mercer Island, WA, USA</nlm:aff></affiliation></author><author><name sortKey="Schiffman, Mark" sort="Schiffman, Mark" uniqKey="Schiffman M" first="Mark" last="Schiffman">Mark Schiffman</name><affiliation><nlm:aff id="A22">National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, MD, USA</nlm:aff></affiliation></author><author><name sortKey="Meijer, Chris J L M" sort="Meijer, Chris J L M" uniqKey="Meijer C" first="Chris J. L. M." last="Meijer">Chris J. L. M. Meijer</name><affiliation><nlm:aff id="A23">Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Sankaranarayanan, Rengaswamy" sort="Sankaranarayanan, Rengaswamy" uniqKey="Sankaranarayanan R" first="Rengaswamy" last="Sankaranarayanan">Rengaswamy Sankaranarayanan</name><affiliation><nlm:aff id="A24">Screening Group, International Agency for Research on Cancer, Lyon, France</nlm:aff></affiliation></author><author><name sortKey="Castellsague, Xavier" sort="Castellsague, Xavier" uniqKey="Castellsague X" first="Xavier" last="Castellsagué">Xavier Castellsagué</name><affiliation><nlm:aff id="A1">Cancer Epidemiology Research Program (CERP), Institut Català d’Oncologia – Catalan Institute of Oncology (ICO), IDIBELL, L’Hospitalet de Llobregat (Barcelona), Spain</nlm:aff></affiliation><affiliation><nlm:aff id="A25">CIBER en Epidemiología y Salud Pública (CIBERESP), Spain</nlm:aff></affiliation></author><author><name sortKey="Kim, Jane J" sort="Kim, Jane J" uniqKey="Kim J" first="Jane J." last="Kim">Jane J. Kim</name><affiliation><nlm:aff id="A26">Center for Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA</nlm:aff></affiliation></author><author><name sortKey="Brotons, Maria" sort="Brotons, Maria" uniqKey="Brotons M" first="Maria" last="Brotons">Maria Brotons</name><affiliation><nlm:aff id="A1">Cancer Epidemiology Research Program (CERP), Institut Català d’Oncologia – Catalan Institute of Oncology (ICO), IDIBELL, L’Hospitalet de Llobregat (Barcelona), Spain</nlm:aff></affiliation></author><author><name sortKey="Alemany, Laia" sort="Alemany, Laia" uniqKey="Alemany L" first="Laia" last="Alemany">Laia Alemany</name><affiliation><nlm:aff id="A1">Cancer Epidemiology Research Program (CERP), Institut Català d’Oncologia – Catalan Institute of Oncology (ICO), IDIBELL, L’Hospitalet de Llobregat (Barcelona), Spain</nlm:aff></affiliation><affiliation><nlm:aff id="A25">CIBER en Epidemiología y Salud Pública (CIBERESP), Spain</nlm:aff></affiliation></author><author><name sortKey="Albero, Ginesa" sort="Albero, Ginesa" uniqKey="Albero G" first="Ginesa" last="Albero">Ginesa Albero</name><affiliation><nlm:aff id="A1">Cancer Epidemiology Research Program (CERP), Institut Català d’Oncologia – Catalan Institute of Oncology (ICO), IDIBELL, L’Hospitalet de Llobregat (Barcelona), Spain</nlm:aff></affiliation><affiliation><nlm:aff id="A25">CIBER en Epidemiología y Salud Pública (CIBERESP), Spain</nlm:aff></affiliation></author><author><name sortKey="Diaz, Mireia" sort="Diaz, Mireia" uniqKey="Diaz M" first="Mireia" last="Diaz">Mireia Diaz</name><affiliation><nlm:aff id="A1">Cancer Epidemiology Research Program (CERP), Institut Català d’Oncologia – Catalan Institute of Oncology (ICO), IDIBELL, L’Hospitalet de Llobregat (Barcelona), Spain</nlm:aff></affiliation></author><author><name sortKey="De Sanjose, Silvia" sort="De Sanjose, Silvia" uniqKey="De Sanjose S" first="Silvia" last="De Sanjosé">Silvia De Sanjosé</name><affiliation><nlm:aff id="A1">Cancer Epidemiology Research Program (CERP), Institut Català d’Oncologia – Catalan Institute of Oncology (ICO), IDIBELL, L’Hospitalet de Llobregat (Barcelona), Spain</nlm:aff></affiliation><affiliation><nlm:aff id="A25">CIBER en Epidemiología y Salud Pública (CIBERESP), Spain</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">24229716</idno><idno type="pmc">4062073</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062073</idno><idno type="RBID">PMC:4062073</idno><idno type="doi">10.1016/j.vaccine.2013.07.026</idno><date when="2013">2013</date><idno type="wicri:Area/Pmc/Corpus">002025</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002025</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Comprehensive Control of Human Papillomavirus Infections and Related Diseases</title><author><name sortKey="Bosch, F Xavier" sort="Bosch, F Xavier" uniqKey="Bosch F" first="F. Xavier" last="Bosch">F. Xavier Bosch</name><affiliation><nlm:aff id="A1">Cancer Epidemiology Research Program (CERP), Institut Català d’Oncologia – Catalan Institute of Oncology (ICO), IDIBELL, L’Hospitalet de Llobregat (Barcelona), Spain</nlm:aff></affiliation></author><author><name sortKey="Broker, Thomas R" sort="Broker, Thomas R" uniqKey="Broker T" first="Thomas R." last="Broker">Thomas R. Broker</name><affiliation><nlm:aff id="A2">University of Alabama at Birmingham, Biochemistry and Molecular Genetics, Birmingham, Alabama, USA</nlm:aff></affiliation></author><author><name sortKey="Forman, David" sort="Forman, David" uniqKey="Forman D" first="David" last="Forman">David Forman</name><affiliation><nlm:aff id="A3">Section of Cancer Information, International Agency for Research on Cancer, Lyon, France</nlm:aff></affiliation></author><author><name sortKey="Moscicki, Anna Barbara" sort="Moscicki, Anna Barbara" uniqKey="Moscicki A" first="Anna-Barbara" last="Moscicki">Anna-Barbara Moscicki</name><affiliation><nlm:aff id="A4">Division of Adolescent Medicine, Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA</nlm:aff></affiliation></author><author><name sortKey="Gillison, Maura L" sort="Gillison, Maura L" uniqKey="Gillison M" first="Maura L." last="Gillison">Maura L. Gillison</name><affiliation><nlm:aff id="A5">Viral Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA</nlm:aff></affiliation></author><author><name sortKey="Doorbar, John" sort="Doorbar, John" uniqKey="Doorbar J" first="John" last="Doorbar">John Doorbar</name><affiliation><nlm:aff id="A6">Division of Virology, National Institute for Medical Research, London, UK</nlm:aff></affiliation></author><author><name sortKey="Stern, Peter L" sort="Stern, Peter L" uniqKey="Stern P" first="Peter L." last="Stern">Peter L. Stern</name><affiliation><nlm:aff id="A7">Paterson Institute for Cancer Research, University of Manchester, Manchester, UK</nlm:aff></affiliation></author><author><name sortKey="Stanley, Margaret" sort="Stanley, Margaret" uniqKey="Stanley M" first="Margaret" last="Stanley">Margaret Stanley</name><affiliation><nlm:aff id="A8">Department of Pathology, Tennis Court Road, Cambridge, UK</nlm:aff></affiliation></author><author><name sortKey="Arbyn, Marc" sort="Arbyn, Marc" uniqKey="Arbyn M" first="Marc" last="Arbyn">Marc Arbyn</name><affiliation><nlm:aff id="A9">Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium</nlm:aff></affiliation><affiliation><nlm:aff id="A10">Laboratory for Cell Biology and Histology, University of Antwerp, Antwerp, Belgium</nlm:aff></affiliation></author><author><name sortKey="Poljak, Mario" sort="Poljak, Mario" uniqKey="Poljak M" first="Mario" last="Poljak">Mario Poljak</name><affiliation><nlm:aff id="A11">Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia</nlm:aff></affiliation></author><author><name sortKey="Cuzick, Jack" sort="Cuzick, Jack" uniqKey="Cuzick J" first="Jack" last="Cuzick">Jack Cuzick</name><affiliation><nlm:aff id="A12">Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK</nlm:aff></affiliation></author><author><name sortKey="Castle, Philip E" sort="Castle, Philip E" uniqKey="Castle P" first="Philip E." last="Castle">Philip E. Castle</name><affiliation><nlm:aff id="A13">Global Cancer Initiative, Chestertown, MD, USA</nlm:aff></affiliation></author><author><name sortKey="Schiller, John T" sort="Schiller, John T" uniqKey="Schiller J" first="John T." last="Schiller">John T. Schiller</name><affiliation><nlm:aff id="A14">Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA</nlm:aff></affiliation></author><author><name sortKey="Markowitz, Lauri E" sort="Markowitz, Lauri E" uniqKey="Markowitz L" first="Lauri E." last="Markowitz">Lauri E. Markowitz</name><affiliation><nlm:aff id="A15">National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA</nlm:aff></affiliation></author><author><name sortKey="Fisher, William A" sort="Fisher, William A" uniqKey="Fisher W" first="William A." last="Fisher">William A. Fisher</name><affiliation><nlm:aff id="A16">Department of Psychology and Department of Obstetrics and Gynaecology, University of Western Ontario, Social Sciences Centre 7428, London, Ontario, Canada</nlm:aff></affiliation></author><author><name sortKey="Canfell, Karen" sort="Canfell, Karen" uniqKey="Canfell K" first="Karen" last="Canfell">Karen Canfell</name><affiliation><nlm:aff id="A17">Lowy Cancer Research Centre, Prince of Wales Clinical School, The University of NSW, Australia and Cancer Epidemiology Research Unit, Cancer Council NSW, Sydney, Australia (past affiliation)</nlm:aff></affiliation></author><author><name sortKey="Denny, Lynette A" sort="Denny, Lynette A" uniqKey="Denny L" first="Lynette A." last="Denny">Lynette A. Denny</name><affiliation><nlm:aff id="A18">Department Obstetrics and Gynaecology and Institute of Infectious Diseases and Molecular Medicine, University of Cape Town/Groote Schuur Hospital, Cape Town, South Africa</nlm:aff></affiliation></author><author><name sortKey="Franco, Eduardo L" sort="Franco, Eduardo L" uniqKey="Franco E" first="Eduardo L." last="Franco">Eduardo L. Franco</name><affiliation><nlm:aff id="A19">Division of Cancer Epidemiology, McGill University, Montreal, Canada</nlm:aff></affiliation></author><author><name sortKey="Steben, Marc" sort="Steben, Marc" uniqKey="Steben M" first="Marc" last="Steben">Marc Steben</name><affiliation><nlm:aff id="A20">Institut National de Santé Publique du Québec, Montréal, Québec, Canada</nlm:aff></affiliation></author><author><name sortKey="Kane, Mark A" sort="Kane, Mark A" uniqKey="Kane M" first="Mark A." last="Kane">Mark A. Kane</name><affiliation><nlm:aff id="A21">Consultant on Immunization Policy, Mercer Island, WA, USA</nlm:aff></affiliation></author><author><name sortKey="Schiffman, Mark" sort="Schiffman, Mark" uniqKey="Schiffman M" first="Mark" last="Schiffman">Mark Schiffman</name><affiliation><nlm:aff id="A22">National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, MD, USA</nlm:aff></affiliation></author><author><name sortKey="Meijer, Chris J L M" sort="Meijer, Chris J L M" uniqKey="Meijer C" first="Chris J. L. M." last="Meijer">Chris J. L. M. Meijer</name><affiliation><nlm:aff id="A23">Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands</nlm:aff></affiliation></author><author><name sortKey="Sankaranarayanan, Rengaswamy" sort="Sankaranarayanan, Rengaswamy" uniqKey="Sankaranarayanan R" first="Rengaswamy" last="Sankaranarayanan">Rengaswamy Sankaranarayanan</name><affiliation><nlm:aff id="A24">Screening Group, International Agency for Research on Cancer, Lyon, France</nlm:aff></affiliation></author><author><name sortKey="Castellsague, Xavier" sort="Castellsague, Xavier" uniqKey="Castellsague X" first="Xavier" last="Castellsagué">Xavier Castellsagué</name><affiliation><nlm:aff id="A1">Cancer Epidemiology Research Program (CERP), Institut Català d’Oncologia – Catalan Institute of Oncology (ICO), IDIBELL, L’Hospitalet de Llobregat (Barcelona), Spain</nlm:aff></affiliation><affiliation><nlm:aff id="A25">CIBER en Epidemiología y Salud Pública (CIBERESP), Spain</nlm:aff></affiliation></author><author><name sortKey="Kim, Jane J" sort="Kim, Jane J" uniqKey="Kim J" first="Jane J." last="Kim">Jane J. Kim</name><affiliation><nlm:aff id="A26">Center for Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA</nlm:aff></affiliation></author><author><name sortKey="Brotons, Maria" sort="Brotons, Maria" uniqKey="Brotons M" first="Maria" last="Brotons">Maria Brotons</name><affiliation><nlm:aff id="A1">Cancer Epidemiology Research Program (CERP), Institut Català d’Oncologia – Catalan Institute of Oncology (ICO), IDIBELL, L’Hospitalet de Llobregat (Barcelona), Spain</nlm:aff></affiliation></author><author><name sortKey="Alemany, Laia" sort="Alemany, Laia" uniqKey="Alemany L" first="Laia" last="Alemany">Laia Alemany</name><affiliation><nlm:aff id="A1">Cancer Epidemiology Research Program (CERP), Institut Català d’Oncologia – Catalan Institute of Oncology (ICO), IDIBELL, L’Hospitalet de Llobregat (Barcelona), Spain</nlm:aff></affiliation><affiliation><nlm:aff id="A25">CIBER en Epidemiología y Salud Pública (CIBERESP), Spain</nlm:aff></affiliation></author><author><name sortKey="Albero, Ginesa" sort="Albero, Ginesa" uniqKey="Albero G" first="Ginesa" last="Albero">Ginesa Albero</name><affiliation><nlm:aff id="A1">Cancer Epidemiology Research Program (CERP), Institut Català d’Oncologia – Catalan Institute of Oncology (ICO), IDIBELL, L’Hospitalet de Llobregat (Barcelona), Spain</nlm:aff></affiliation><affiliation><nlm:aff id="A25">CIBER en Epidemiología y Salud Pública (CIBERESP), Spain</nlm:aff></affiliation></author><author><name sortKey="Diaz, Mireia" sort="Diaz, Mireia" uniqKey="Diaz M" first="Mireia" last="Diaz">Mireia Diaz</name><affiliation><nlm:aff id="A1">Cancer Epidemiology Research Program (CERP), Institut Català d’Oncologia – Catalan Institute of Oncology (ICO), IDIBELL, L’Hospitalet de Llobregat (Barcelona), Spain</nlm:aff></affiliation></author><author><name sortKey="De Sanjose, Silvia" sort="De Sanjose, Silvia" uniqKey="De Sanjose S" first="Silvia" last="De Sanjosé">Silvia De Sanjosé</name><affiliation><nlm:aff id="A1">Cancer Epidemiology Research Program (CERP), Institut Català d’Oncologia – Catalan Institute of Oncology (ICO), IDIBELL, L’Hospitalet de Llobregat (Barcelona), Spain</nlm:aff></affiliation><affiliation><nlm:aff id="A25">CIBER en Epidemiología y Salud Pública (CIBERESP), Spain</nlm:aff></affiliation></author></analytic><series><title level="j">Vaccine</title><idno type="ISSN">0264-410X</idno><idno type="eISSN">1873-2518</idno><imprint><date when="2013">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p id="P1">Infection with human papillomavirus (HPV) is recognized as one of the major causes of infection-related cancer worldwide, as well as the causal factor in other diseases. Strong evidence for a causal etiology with HPV has been stated by the International Agency for Research on Cancer for cancers of the cervix uteri, penis, vulva, vagina, anus and oropharynx (including base of the tongue and tonsils). Of the estimated 12.7 million new cancers occurring in 2008 worldwide, 4.8% were attributable to HPV infection, with substantially higher incidence and mortality rates seen in developing versus developed countries. In recent years, we have gained tremendous knowledge about HPVs and their interactions with host cells, tissues and the immune system; have validated and implemented strategies for safe and efficacious prophylactic vaccination against HPV infections; have developed increasingly sensitive and specific molecular diagnostic tools for HPV detection for use in cervical cancer screening; and have substantially increased global awareness of HPV and its many associated diseases in women, men, and children. While these achievements exemplify the success of biomedical research in generating important public health interventions, they also generate new and daunting challenges: costs of HPV prevention and medical care, the implementation of what is technically possible, socio-political resistance to prevention opportunities, and the very wide ranges of national economic capabilities and health care systems. Gains and challenges faced in the quest for comprehensive control of HPV infection and HPV-related cancers and other disease are summarized in this review. The information presented may be viewed in terms of a reframed paradigm of prevention of cervical cancer and other HPV-related diseases that will include strategic combinations of at least four major components: 1) routine introduction of HPV vaccines to women in all countries, 2) extension and simplification of existing screening programs using HPV-based technology, 3) extension of adapted screening programs to developing populations, and 4) consideration of the broader spectrum of cancers and other diseases preventable by HPV vaccination in women, as well as in men. Despite the huge advances already achieved, there must be ongoing efforts including international advocacy to achieve widespread—optimally universal—implementation of HPV prevention strategies in both developed and developing countries.</p><p id="P2">This article summarizes information from the chapters presented in a special ICO Monograph ‘<italic>Comprehensive Control of HPV Infections and Related Diseases</italic>’ Vaccine Volume 30, Supplement 5, 2012. Additional details on each subtopic and full information regarding the supporting literature references may be found in the original chapters.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">8406899</journal-id><journal-id journal-id-type="pubmed-jr-id">7945</journal-id><journal-id journal-id-type="nlm-ta">Vaccine</journal-id><journal-id journal-id-type="iso-abbrev">Vaccine</journal-id><journal-title-group><journal-title>Vaccine</journal-title></journal-title-group><issn pub-type="ppub">0264-410X</issn><issn pub-type="epub">1873-2518</issn></journal-meta><article-meta><article-id pub-id-type="pmid">24229716</article-id><article-id pub-id-type="pmc">4062073</article-id><article-id pub-id-type="doi">10.1016/j.vaccine.2013.07.026</article-id><article-id pub-id-type="manuscript">NIHMS528030</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Comprehensive Control of Human Papillomavirus Infections and Related Diseases</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bosch</surname><given-names>F. Xavier</given-names></name><xref ref-type="aff" rid="A1">a</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>Broker</surname><given-names>Thomas R.</given-names></name><xref ref-type="aff" rid="A2">b</xref></contrib><contrib contrib-type="author"><name><surname>Forman</surname><given-names>David</given-names></name><xref ref-type="aff" rid="A3">c</xref></contrib><contrib contrib-type="author"><name><surname>Moscicki</surname><given-names>Anna-Barbara</given-names></name><xref ref-type="aff" rid="A4">d</xref></contrib><contrib contrib-type="author"><name><surname>Gillison</surname><given-names>Maura L.</given-names></name><xref ref-type="aff" rid="A5">e</xref></contrib><contrib contrib-type="author"><name><surname>Doorbar</surname><given-names>John</given-names></name><xref ref-type="aff" rid="A6">f</xref></contrib><contrib contrib-type="author"><name><surname>Stern</surname><given-names>Peter L.</given-names></name><xref ref-type="aff" rid="A7">g</xref></contrib><contrib contrib-type="author"><name><surname>Stanley</surname><given-names>Margaret</given-names></name><xref ref-type="aff" rid="A8">h</xref></contrib><contrib contrib-type="author"><name><surname>Arbyn</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="A9">i</xref><xref ref-type="aff" rid="A10">j</xref></contrib><contrib contrib-type="author"><name><surname>Poljak</surname><given-names>Mario</given-names></name><xref ref-type="aff" rid="A11">k</xref></contrib><contrib contrib-type="author"><name><surname>Cuzick</surname><given-names>Jack</given-names></name><xref ref-type="aff" rid="A12">l</xref></contrib><contrib contrib-type="author"><name><surname>Castle</surname><given-names>Philip E.</given-names></name><xref ref-type="aff" rid="A13">m</xref></contrib><contrib contrib-type="author"><name><surname>Schiller</surname><given-names>John T.</given-names></name><xref ref-type="aff" rid="A14">n</xref></contrib><contrib contrib-type="author"><name><surname>Markowitz</surname><given-names>Lauri E.</given-names></name><xref ref-type="aff" rid="A15">o</xref></contrib><contrib contrib-type="author"><name><surname>Fisher</surname><given-names>William A.</given-names></name><xref ref-type="aff" rid="A16">p</xref></contrib><contrib contrib-type="author"><name><surname>Canfell</surname><given-names>Karen</given-names></name><xref ref-type="aff" rid="A17">q</xref></contrib><contrib contrib-type="author"><name><surname>Denny</surname><given-names>Lynette A.</given-names></name><xref ref-type="aff" rid="A18">r</xref></contrib><contrib contrib-type="author"><name><surname>Franco</surname><given-names>Eduardo L.</given-names></name><xref ref-type="aff" rid="A19">s</xref></contrib><contrib contrib-type="author"><name><surname>Steben</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="A20">t</xref></contrib><contrib contrib-type="author"><name><surname>Kane</surname><given-names>Mark A.</given-names></name><xref ref-type="aff" rid="A21">u</xref></contrib><contrib contrib-type="author"><name><surname>Schiffman</surname><given-names>Mark</given-names></name><xref ref-type="aff" rid="A22">v</xref></contrib><contrib contrib-type="author"><name><surname>Meijer</surname><given-names>Chris J.L.M.</given-names></name><xref ref-type="aff" rid="A23">w</xref></contrib><contrib contrib-type="author"><name><surname>Sankaranarayanan</surname><given-names>Rengaswamy</given-names></name><xref ref-type="aff" rid="A24">x</xref></contrib><contrib contrib-type="author"><name><surname>Castellsagué</surname><given-names>Xavier</given-names></name><xref ref-type="aff" rid="A1">a</xref><xref ref-type="aff" rid="A25">y</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Jane J.</given-names></name><xref ref-type="aff" rid="A26">z</xref></contrib><contrib contrib-type="author"><name><surname>Brotons</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>Alemany</surname><given-names>Laia</given-names></name><xref ref-type="aff" rid="A1">a</xref><xref ref-type="aff" rid="A25">y</xref></contrib><contrib contrib-type="author"><name><surname>Albero</surname><given-names>Ginesa</given-names></name><xref ref-type="aff" rid="A1">a</xref><xref ref-type="aff" rid="A25">y</xref></contrib><contrib contrib-type="author"><name><surname>Diaz</surname><given-names>Mireia</given-names></name><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>de Sanjosé</surname><given-names>Silvia</given-names></name><xref ref-type="aff" rid="A1">a</xref><xref ref-type="aff" rid="A25">y</xref></contrib><on-behalf-of>on behalf of the authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012</on-behalf-of></contrib-group><aff id="A1"><label>a</label>Cancer Epidemiology Research Program (CERP), Institut Català d’Oncologia – Catalan Institute of Oncology (ICO), IDIBELL, L’Hospitalet de Llobregat (Barcelona), Spain</aff><aff id="A2"><label>b</label>University of Alabama at Birmingham, Biochemistry and Molecular Genetics, Birmingham, Alabama, USA</aff><aff id="A3"><label>c</label>Section of Cancer Information, International Agency for Research on Cancer, Lyon, France</aff><aff id="A4"><label>d</label>Division of Adolescent Medicine, Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA</aff><aff id="A5"><label>e</label>Viral Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA</aff><aff id="A6"><label>f</label>Division of Virology, National Institute for Medical Research, London, UK</aff><aff id="A7"><label>g</label>Paterson Institute for Cancer Research, University of Manchester, Manchester, UK</aff><aff id="A8"><label>h</label>Department of Pathology, Tennis Court Road, Cambridge, UK</aff><aff id="A9"><label>i</label>Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium</aff><aff id="A10"><label>j</label>Laboratory for Cell Biology and Histology, University of Antwerp, Antwerp, Belgium</aff><aff id="A11"><label>k</label>Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia</aff><aff id="A12"><label>l</label>Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK</aff><aff id="A13"><label>m</label>Global Cancer Initiative, Chestertown, MD, USA</aff><aff id="A14"><label>n</label>Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA</aff><aff id="A15"><label>o</label>National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA</aff><aff id="A16"><label>p</label>Department of Psychology and Department of Obstetrics and Gynaecology, University of Western Ontario, Social Sciences Centre 7428, London, Ontario, Canada</aff><aff id="A17"><label>q</label>Lowy Cancer Research Centre, Prince of Wales Clinical School, The University of NSW, Australia and Cancer Epidemiology Research Unit, Cancer Council NSW, Sydney, Australia (past affiliation)</aff><aff id="A18"><label>r</label>Department Obstetrics and Gynaecology and Institute of Infectious Diseases and Molecular Medicine, University of Cape Town/Groote Schuur Hospital, Cape Town, South Africa</aff><aff id="A19"><label>s</label>Division of Cancer Epidemiology, McGill University, Montreal, Canada</aff><aff id="A20"><label>t</label>Institut National de Santé Publique du Québec, Montréal, Québec, Canada</aff><aff id="A21"><label>u</label>Consultant on Immunization Policy, Mercer Island, WA, USA</aff><aff id="A22"><label>v</label>National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, MD, USA</aff><aff id="A23"><label>w</label>Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands</aff><aff id="A24"><label>x</label>Screening Group, International Agency for Research on Cancer, Lyon, France</aff><aff id="A25"><label>y</label>CIBER en Epidemiología y Salud Pública (CIBERESP), Spain</aff><aff id="A26"><label>z</label>Center for Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA</aff><author-notes><corresp id="FN1"><label>*</label>Corresponding author. Tel.: +34 93 2607812; fax: +34 93 2607787. <email>admincerp@iconcologia.net</email> (F.X. Bosch)</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>10</day><month>5</month><year>2014</year></pub-date><pub-date pub-type="ppub"><day>22</day><month>11</month><year>2013</year></pub-date><pub-date pub-type="pmc-release"><day>22</day><month>11</month><year>2014</year></pub-date><volume>31</volume><issue>0 8</issue><fpage>I1</fpage><lpage>31</lpage><pmc-comment>elocation-id from pubmed: 10.1016/j.vaccine.2013.07.026</pmc-comment>
<permissions><copyright-statement>© 2013 Elsevier Ltd. All rights reserved.</copyright-statement><copyright-year>2013</copyright-year></permissions><abstract><p id="P1">Infection with human papillomavirus (HPV) is recognized as one of the major causes of infection-related cancer worldwide, as well as the causal factor in other diseases. Strong evidence for a causal etiology with HPV has been stated by the International Agency for Research on Cancer for cancers of the cervix uteri, penis, vulva, vagina, anus and oropharynx (including base of the tongue and tonsils). Of the estimated 12.7 million new cancers occurring in 2008 worldwide, 4.8% were attributable to HPV infection, with substantially higher incidence and mortality rates seen in developing versus developed countries. In recent years, we have gained tremendous knowledge about HPVs and their interactions with host cells, tissues and the immune system; have validated and implemented strategies for safe and efficacious prophylactic vaccination against HPV infections; have developed increasingly sensitive and specific molecular diagnostic tools for HPV detection for use in cervical cancer screening; and have substantially increased global awareness of HPV and its many associated diseases in women, men, and children. While these achievements exemplify the success of biomedical research in generating important public health interventions, they also generate new and daunting challenges: costs of HPV prevention and medical care, the implementation of what is technically possible, socio-political resistance to prevention opportunities, and the very wide ranges of national economic capabilities and health care systems. Gains and challenges faced in the quest for comprehensive control of HPV infection and HPV-related cancers and other disease are summarized in this review. The information presented may be viewed in terms of a reframed paradigm of prevention of cervical cancer and other HPV-related diseases that will include strategic combinations of at least four major components: 1) routine introduction of HPV vaccines to women in all countries, 2) extension and simplification of existing screening programs using HPV-based technology, 3) extension of adapted screening programs to developing populations, and 4) consideration of the broader spectrum of cancers and other diseases preventable by HPV vaccination in women, as well as in men. Despite the huge advances already achieved, there must be ongoing efforts including international advocacy to achieve widespread—optimally universal—implementation of HPV prevention strategies in both developed and developing countries.</p><p id="P2">This article summarizes information from the chapters presented in a special ICO Monograph ‘<italic>Comprehensive Control of HPV Infections and Related Diseases</italic>’ Vaccine Volume 30, Supplement 5, 2012. Additional details on each subtopic and full information regarding the supporting literature references may be found in the original chapters.</p></abstract><kwd-group><kwd>HPV</kwd><kwd>Cervical cancer</kwd><kwd>Anal cancer</kwd><kwd>Penile cancer</kwd><kwd>Vaginal cancer</kwd><kwd>Vulvar cancer</kwd><kwd>Oropharyngeal cancer</kwd><kwd>Screening</kwd><kwd>HPV vaccination</kwd><kwd>HPV testing</kwd><kwd>Prevention</kwd></kwd-group></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002025 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 002025 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.33. |  |